Concepedia

Rotem Bril

RB

Statistics

Publications

8

Citations

373

H-Index

8

Active since

2011

Affiliations

Technion – Israel Institute of Technology(Current)

Rambam Health Care Campus

Rappaport Family Institute for Research in the Medical Sciences

Roche (Switzerland)

Emek Medical Center

Rotem Bril is an author at Technion – Israel Institute of Technology specializing in oncology, medicine, and chemotherapy.

Publications per year

2011–2015

8

Publications

8

Host Response to Short-term, Single-Agent Chemotherapy Induces Matrix Metalloproteinase-9 Expression and Accelerates Metastasis in Mice

Svetlana Gingis‐Velitski, David Loven, Liat Benayoun et al. · Cancer Research · 2011 · 118 citations

, , +16

G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist

Tali Voloshin, Svetlana Gingis‐Velitski, Rotem Bril et al. · Blood · 2011 · 69 citations

, , +13

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy

Erez Hasnis, Dror Alishekevitz, Svetlana Gingis-Veltski et al. · Neoplasia · 2014 · 63 citations · Full text

, , +15

Dequalinium blocks macrophage-induced metastasis following local radiation

Michael Timaner, Rotem Bril, Orit Kaidar‐Person et al. · Oncotarget · 2015 · 37 citations · Full text

, , +17

Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: A process regulated by osteopontin

Ella Fremder, Michal Munster, Anat Aharon et al. · International Journal of Cancer · 2013 · 34 citations

, , +16

1–5 of 8